Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-03 Purchase | 2023-04-04 5:10 pm | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 8,809 | $2.2157 | $19,518 | 26,809 (Direct) | View |
| 2023-03-16 Purchase | 2023-03-16 5:10 pm | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 26,000 | $2.039 | $53,014 | 1,179,098 (Indirect Direct) | View |
| 2023-03-14 Purchase | 2023-03-15 5:25 pm | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 100,000 | $2.01 | $201,000 | 1,153,098 (Indirect Direct) | View |
| 2023-03-14 Sale | 2023-03-15 5:20 pm | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 100,000 | $2.01 | $201,000 | 201,666 (Direct) | View |
| 2023-03-13 Purchase | 2023-03-15 5:15 pm | ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director | 70,000 | $2.0224 | $141,570 | 86,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-07 Option Award | 2024-11-08 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Gabay Avraham Chief Financial Officer | 30,000 | $0 | 170,040 (Direct) | View |
| 2024-11-07 Option Award | 2024-11-08 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 45,000 | $0 | 1,952,098 (Direct) | View |
| 2024-11-07 Option Award | 2024-11-08 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 30,000 | $0 | 793,666 (Direct) | View |
| 2024-11-07 Option Award | 2024-11-08 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 30,000 | $0 | 511,833 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 4:15 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Gabay Avraham Chief Financial Officer | 140,040 | $0 | 0 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 5:15 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Reznick Yehuda Director | 760 | $0 | 30,560 (Direct) | View |
| 2024-04-17 Option Award | 2024-04-18 8:07 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Reznick Yehuda Director | 29,800 | $0 | 29,800 (Direct) | View |
| 2024-01-30 Option Award | 2024-01-30 5:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Aghion Daniel Director | 3,750 | $0 | 38,820 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:43 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 295,500 | $0 | 763,666 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:41 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 329,000 | $0 | 1,907,098 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:40 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 180,500 | $0 | 481,833 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:39 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 136,500 | $0 | 366,500 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:37 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 39,325 | $0 | 98,021 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:36 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director | 38,820 | $0 | 155,320 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:34 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 39,325 | $0 | 96,134 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:33 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Aghion Daniel Director | 35,070 | $0 | 35,070 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:32 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Shapiro Benjamin Director | 35,070 | $0 | 1,955,070 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 120,000 | $0 | 1,578,098 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 53,500 | $0 | 468,166 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Derovan Netanel Chief Legal Officer | 20,500 | $0 | 149,500 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 27,000 | $0 | 301,333 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 24,500 | $0 | 230,000 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-01 5:12 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Shapiro Benjamin Director | 20,000 | $0 | 1,920,000 (Direct) | View |
Ownership | 2023-05-01 5:07 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Shapiro Benjamin Director | 0 | $0 | 1,900,000 (Indirect) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 30,000 | $0 | 58,696 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Derovan Netanel Chief Legal Officer | 81,000 | $0 | 129,000 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 108,000 | $0 | 274,333 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 279,000 | $0 | 1,458,098 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director | 30,000 | $0 | 116,500 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 213,000 | $0 | 414,666 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 97,500 | $0 | 205,500 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 30,000 | $0 | 56,809 (Direct) | View |